Concentration of IL-2, IL-6, IL-8, IL-10 and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy

Hematological Oncology

Volumn 22, Issue 1, 2004, Pages 27-34

  Mazur, Bogdan ^a   Mertas, Anna ^a   Sońta Jakimczyk, Danuta ^a   Szczepański, Tomasz ^a   Janik Moszant, Anna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acute lymphoblastic leukemia; Children; Cytokines

Indexed keywords

CYTOTOXIC AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL GROWTH; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOASSAY; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-6; INTERLEUKIN-8; LEUKEMIA, LYMPHOCYTIC, ACUTE; REFERENCE VALUES; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2642574048     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/hon.725     Document Type: Review

References (30)

1. Brenner MK, Pinkel D. Cure of leukemia. Semin Hematol 1999; 36: 73-83.
2. Miller RW, Young JL, Novakovic B. Childhood cancer. Cancer 1995; 75: 395-405.
3. Robison LL. General principles of the epidemiology of childhood cancer. In Principles and Practice of Pediatric Oncology, Pizzo PA, Poplack DG, Pizzo PA, Poplack DG (eds). Lippincott-Raven: Philadelphia, New York, 1997; 1-10.
4. Bruserud O, Ulvestad E. Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells. Cancer Immunol Immunother 2003; 52: 215-225.
5. Tossing G. Immunodeficiency and its relation to lymphoid and other malignancies. Ann Hematol 1996; 73: 163-167.
6. Bellanti JA, Kadlec JV, Escobar-Gutierrez A. Cytokines and the immune response. Pediatr Clin North Am 1994; 41: 597-621.
7. Borish L, Rosenwasser LJ. Update on cytokines. J Allergy Clin Immunol 1996; 97: 719-734.
8. Baraldi-Junkins CA, Beck AC, Rothstein G. Hematopoiesis and cytokines. Hematol Oncol Clin Amer 2000; 14: 45-61.
9. Stevens DL. Cytokines: an updated compendium. Current Opin Inf Dis 1995; 8: 175-180.
10. Ihle JN. Cytokine receptor signaling. Nature 1994; 377: 591-594.
11. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994; 76: 253-262.
12. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 2003; 374: 1-20.
13. Houssiau FA, Schandene L, Stevens M, et al. A cascade of cytokines is responsible for IL-9 expression in human T cell. Involvement of IL-2, IL-4 and IL-10. J Immunol 1995; 154: 2624-2630.
14. Junquan T, Deleuran B, Gesser B, et al. Regulation of human T lymphocytes chemotaxis in vitro by T cell-derived cytokines IL-2, IFN-g, IL-4, IL-10 and IL-13. J Immunol 1995; 154: 3742-3752.
15. Aukrust P, Svardal AM, Muller F, Lunden B, Berge RK, Froland SS. Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of tumor necrosis factor system: possible immunopathogenic role of oxidative stress. Blood 1995; 86: 1383-1391.
16. North ME, Spicett GP, Webster ADB, Farrant J. Raised serum levels of CD8+, CD25 and β-microglobulin in common variable immunodeficiency. Clin Exp Immunol 1991; 86: 252-256.
17. Aukrust P, Lien E, Kristofferson AK, et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency - possible immunologic and clinical consequences. Blood 1996; 87: 674-681.
18. North ME, Ivory K, Funauchi M, Webster ADB, Lane AC, Farrant J. Intracellular cytokine production by human CD4+ and CD8+ cells from normal and immunodeficient donors using directly conjugated anticytokines antibodies and three-colour flow cytomerty. Clin Exp Immunol 1996; 105: 517-522.
19. Kowalczyk D, Mytar B, Zembala M. Cytokine production in transient hypogammmaglobulinemia and isolated IgA deficiency. J Allergy Clin Immunol 1997; 100: 556-562.
20. Zhang XL, Komada Y, Chipeta J, et al. Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia. Cancer Immunol Immunother 2000; 49: 165-172.
21. Zhang XL, Komada Y, Zhou YW, et al. Inhibition of interleukin-2 receptor (CD25) expression induced on T cells from children with acute lymphoblastic leukemia. Cancer Immunol Immunother 1997; 44: 41-49.
22. Adelman DC, Matsuda T, Hirano T, Kishimoto T, Saxon A. Elevated serum interleukin-6 associated with failure in B cell differentiation in common variable immunodeficiency. J Allergy Clin Immunol 1990; 89: 512-521.
23. Matheson DS, Webb BT, Green BJ, et al. Production of factor with B-cell growth and differentiation activities by peripheral blood mononuclear cells from patients with hypogammaglobulinemia. J Allergy Clin Immunol 1994; 93: 126-135.
24. Yee C, Sutcliffe S, Messner H, Minden MD. Interleukin-6 levels in the plasma of patients with lymphoma. Leuk Lymph 1992; 7: 123-129.
25. Pituch-Noworolska A, Wiȩckiewicz J, Gawlicka M, Woloszyn M, Ruggiero I, Zembala M. The IL-6 gene expression by leukemic cells from acute lymphoblastic common and T type and modulation of IL-6 production by TNF. Haematologia 1998; 29: 101-114.
26. Mavridis AK, Tsiara S, Makis A, et al. Interleukins, TNF-α and β-2M in patients with B cell chronic lymphocytic leukemia. J Exp Clin Cancer Res 1998; 17: 445-448.
27. Watari K, Tojo A, Nagamura IT, et al. Hyperfunction of neutrophils in a patient with BCR/ABL negative myeliod leukemia: a case report with in vitro studies. Cancer 2000; 89: 551-560.
28. Wierda WG, Johnson MM, Do KA, et al. Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia. Br J Haematol 2003; 120: 452-456.
29. Webster DAB, North ME, Fanauchi M, Farrant J. The etiology and mechanisms of CVID. Pol J Immunol 1993; 18: 309-317.
30. Zuniga-Pfucker JC, Lenardo M. Regulation of thymocyte development from immature progenitors. Curr Opin Immunol 1996; 8: 215-224.